- Home
- INDV vs HHH Comparison
INDV vs HHH Comparison
Compare INDV & HHH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | INDV | HHH |
|---|---|---|
| Founded | N/A | 2010 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Real Estate Investment Trusts |
| Sector | Health Care | Real Estate |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 3.7B | 3.9B |
| IPO Year | 2014 | 2023 |
Fundamental Metrics
Financial Performance| Metric | INDV | HHH |
|---|---|---|
| Price | $32.56 | $67.48 |
| Analyst Decision | | Buy |
| Analyst Count | 0 | 2 |
| Target Price | N/A | ★ $90.00 |
| AVG Volume (30 Days) | ★ 1.8M | 357.6K |
| Earning Date | 06-08-2026 | 05-07-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 8100.00 | N/A |
| EPS | 1.64 | ★ 2.21 |
| Revenue | $1,239,000,000.00 | ★ $1,474,892,000.00 |
| Revenue This Year | N/A | $14.04 |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | ★ $19.95 | $29.86 |
| Revenue Growth | ★ 4.29 | N/A |
| 52 Week Low | $8.69 | $61.01 |
| 52 Week High | $38.00 | $91.07 |
Technical Indicators
Market Signals| Indicator | INDV | HHH |
|---|---|---|
| Relative Strength Index (RSI) | 54.69 | 59.34 |
| Support Level | $31.70 | $67.25 |
| Resistance Level | $35.75 | $71.20 |
| Average True Range (ATR) | 1.25 | 1.50 |
| MACD | 0.30 | 0.83 |
| Stochastic Oscillator | 74.01 | 99.00 |
Price Performance
Historical ComparisonAbout INDV Indivior PLC
Indivior Pharmaceuticals Inc is a specialty pharmaceutical company singularly focused on delivering evidence-based treatment and advancing understanding of opioid use disorder (OUD) as a chronic but treatable brain disease. The company derives revenues from customers through the development, manufacture and sale of buprenorphine-based prescription drugs for treatment of opioid dependence and related disorders. The company's products include: Sublocade (buprenorphine extended-release monthly injection), and Suboxone (buprenorphine and naloxone sublingual film).
About HHH Howard Hughes Holdings Inc.
Howard Hughes Holdings Inc, through its subsidiary, operates a large-scale, mixed-use real estate platform focused on the development of master planned communities (MPCs), the investment in strategic real estate development opportunities, and the ownership and operation of income-producing properties. The group operates through three reportable business segments: Operating Assets, MPCs, and Strategic Developments. Maximum revenue is generated from the MPC segment, which consists of the development and sale of land in large-scale, long-term community development projects in and around Las Vegas, Nevada; Houston, Texas; and Phoenix, Arizona. Revenues are mainly generated through the sale of residential and commercial land to homebuilders and developers.